Skip to content
OpenCapital
Get started

Enveric Biosciences ENVB Q3 2025 earnings

Reported November 14, 2025 · Before market open

EPS-$10.81Beat by $52.19
EPS estimate-$63.00

Next report

Aug 17, 2026 (In 2 weeks)

Versus estimates

Revenue

Q4 2024$340.4K

Diluted EPS

Q1 2026-$1.08Q4 2025$0.85Beat by $56.65
Q3 2025-$10.81Beat by $52.19
Q2 2025-$11.64Beat by $51.36Q1 2025-$1.22Beat by $4.78Q4 2024-$21.89Miss by $18.44

Ask the moment Enveric Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Enveric Biosciences report Q3 2025 earnings?
Enveric Biosciences (ENVB) reported Q3 2025 earnings on November 14, 2025 before market open.
What were Enveric Biosciences's Q3 2025 revenue and EPS?
Enveric Biosciences reported eps of $-10.81 for Q3 2025.
Did Enveric Biosciences beat estimates in Q3 2025?
EPS beat the consensus estimate of $-63.00 by $52.19.
How did Enveric Biosciences's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 200.3% from $-3.60.
Where can I find Enveric Biosciences's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-023444) and the 10-Q periodic report (0001493152-25-023540) directly on SEC EDGAR. The filing index links above go to sec.gov.